| __timestamp | Arrowhead Pharmaceuticals, Inc. | Regeneron Pharmaceuticals, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 23138050 | 1271353000 |
| Thursday, January 1, 2015 | 57410147 | 1620577000 |
| Friday, January 1, 2016 | 41454452 | 2052295000 |
| Sunday, January 1, 2017 | 31690298 | 2075142000 |
| Monday, January 1, 2018 | 52968505 | 2186100000 |
| Tuesday, January 1, 2019 | 81048686 | 3036600000 |
| Wednesday, January 1, 2020 | 128874979 | 2735000000 |
| Friday, January 1, 2021 | 206342000 | 2908100000 |
| Saturday, January 1, 2022 | 297307000 | 3592500000 |
| Sunday, January 1, 2023 | 353188000 | 4439000000 |
| Monday, January 1, 2024 | 505870000 | 5132000000 |
Unleashing insights
In the competitive world of biotechnology, investment in research and development (R&D) is a key driver of innovation. Over the past decade, Regeneron Pharmaceuticals, Inc. has consistently outpaced Arrowhead Pharmaceuticals, Inc. in R&D spending. From 2014 to 2023, Regeneron's R&D expenses grew by approximately 250%, peaking in 2023 with a staggering $4.4 billion. In contrast, Arrowhead's investment, while growing significantly by over 200%, reached $353 million in 2023. This disparity highlights Regeneron's commitment to maintaining its leadership in the biotech sector. However, Arrowhead's steady increase in R&D spending signals its ambition to expand its innovative capabilities. As we look to the future, the question remains: will Arrowhead close the gap, or will Regeneron continue to dominate the innovation landscape?
Comparing Innovation Spending: AbbVie Inc. and Arrowhead Pharmaceuticals, Inc.
Research and Development Expenses Breakdown: Regeneron Pharmaceuticals, Inc. vs Blueprint Medicines Corporation
R&D Spending Showdown: Regeneron Pharmaceuticals, Inc. vs Bio-Techne Corporation
Research and Development Investment: Regeneron Pharmaceuticals, Inc. vs Pharming Group N.V.
Analyzing R&D Budgets: Regeneron Pharmaceuticals, Inc. vs Ultragenyx Pharmaceutical Inc.
Analyzing R&D Budgets: Regeneron Pharmaceuticals, Inc. vs Veracyte, Inc.
Regeneron Pharmaceuticals, Inc. vs Agios Pharmaceuticals, Inc.: Strategic Focus on R&D Spending
Who Prioritizes Innovation? R&D Spending Compared for Regeneron Pharmaceuticals, Inc. and MannKind Corporation
Who Prioritizes Innovation? R&D Spending Compared for Regeneron Pharmaceuticals, Inc. and Supernus Pharmaceuticals, Inc.
Comparing Innovation Spending: Insmed Incorporated and Arrowhead Pharmaceuticals, Inc.
Research and Development: Comparing Key Metrics for Blueprint Medicines Corporation and Arrowhead Pharmaceuticals, Inc.
Analyzing R&D Budgets: Alkermes plc vs Arrowhead Pharmaceuticals, Inc.